Abstract
Congenital myasthenic syndromes (CMS) are inherited disorders of neuromuscular transmission associated with abnormal weakness and fatigability on exertion. Clinical, ultrastructural, in vitro microelectrode, and molecular genetic studies of CMS patients has identified a phenotypically and genetically heterogeneous group of disorders. To date, 35 CMS disease genes have been identified. Most disease proteins reside in presynaptic, synaptic basal lamina, or postsynaptic endplate (EP) compartments. This chapter reviews the clinical presentaion, typical features, diagnostic assessments, genetic aspects and treatment opportunities for this group of diseases with impaired neuromuscular transmission.
| Original language | English (US) |
|---|---|
| Title of host publication | Swaiman's Pediatric Neurology |
| Subtitle of host publication | Principles and Practice |
| Publisher | Elsevier |
| Pages | 1433-1439.e3 |
| ISBN (Electronic) | 9780443109447 |
| ISBN (Print) | 9780443111068 |
| DOIs | |
| State | Published - Jan 1 2025 |
Keywords
- congenital myasthenic syndrome
- defective neuromuscular transmission
- fatigue
- neuromuscular junction
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Congenital Myasthenic Syndromes'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS